Charles A. Sanders, Director at GENENTECH INC (DNA), sold 15,000 shares at $71.02 ($1.1M) on 2008-02-06, disclosed to the SEC on 2008-02-08.
Open-market sale of $1.1M DNA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $71.00 | 12,750 | $905K | 85.0% |
| 2 | $71.01 | 100 | $7K | 0.7% |
| 3 | $71.02 | 900 | $64K | 6.0% |
| 4 | $71.04 | 150 | $11K | 1.0% |
| 5 | $71.07 | 300 | $21K | 2.0% |
| 6 | $71.12 | 600 |
| $43K |
| 4.0% |
| 7 | $71.17 | 200 | $14K | 1.3% |
| Total | $71.01 avg | 15,000 | $1.1M | 100% |
| Filing → |
| BIOD | BUY | 2011-08-11 | $12K | — | Filing → |
| BIOD | BUY | 2010-05-13 | $28K | — | Filing → |
| BCRX | BUY | 2010-02-09 | $33K | — | Filing → |